Talis Biomedical to Announce Third Quarter 2021 Financial Results on November 15, 2021
Talis Biomedical Corporation (TLIS) announced it will release its third-quarter financial results on November 15, 2021, after market close. A conference call to discuss the results will follow at 1:30 PM PT (4:30 PM ET). Interested parties can join via phone or access a live webcast through the company's investor website. Talis is focused on developing innovative molecular diagnostic tests for infectious diseases, aiming to provide rapid, low-cost testing at the point of care with its Talis One device.
- Talis is developing the Talis One, a rapid molecular diagnostic instrument designed for point-of-care testing.
- Focus on innovative molecular diagnostic tests for infectious diseases indicates potential market growth.
- None.
MENLO PARK, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that it will release financial results for the third quarter after market close on Monday, November 15, 2021. Talis will host a conference call, beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss financial and operational results.
Interested parties may access the live call via telephone by dialing 833-715-1329 for participants in the U.S. or Canada and 430-775-1933 for international callers, using conference ID 3618139. A live and archived webcast of the event can be accessed via the News & Events page of the investor section of Talis Biomedical’s website at www.talis.bio.
About Talis Biomedical
Talis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost, and rapid molecular testing for infectious diseases at the point of care. The company is developing the Talis One, a compact, sample-to-answer, cloud-enabled, molecular diagnostic instrument. For more information, visit talisbio.com.
Contact
Media & Investors
Emily Faucette
ir@talisbio.com
415-595-9407
FAQ
When will Talis Biomedical's third-quarter financial results be released?
What time is Talis Biomedical's conference call for financial results?
How can I access the Talis Biomedical conference call?
What is Talis Biomedical's focus in the diagnostics market?
